"Bone Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer located in bone tissue or specific BONES.
Descriptor ID |
D001859
|
MeSH Number(s) |
C04.588.149 C05.116.231
|
Concept/Terms |
Bone Neoplasms- Bone Neoplasms
- Bone Neoplasm
- Neoplasm, Bone
- Neoplasms, Bone
|
Below are MeSH descriptors whose meaning is more general than "Bone Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Bone Neoplasms".
This graph shows the total number of publications written about "Bone Neoplasms" by people in this website by year, and whether "Bone Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1998 | 2 | 0 | 2 |
1999 | 4 | 0 | 4 |
2000 | 4 | 1 | 5 |
2001 | 5 | 3 | 8 |
2002 | 3 | 1 | 4 |
2003 | 5 | 2 | 7 |
2004 | 6 | 5 | 11 |
2005 | 8 | 2 | 10 |
2006 | 7 | 1 | 8 |
2007 | 3 | 3 | 6 |
2008 | 4 | 0 | 4 |
2009 | 4 | 0 | 4 |
2010 | 6 | 3 | 9 |
2011 | 8 | 5 | 13 |
2012 | 4 | 2 | 6 |
2013 | 6 | 3 | 9 |
2014 | 8 | 1 | 9 |
2015 | 9 | 0 | 9 |
2016 | 2 | 1 | 3 |
2017 | 6 | 2 | 8 |
2018 | 7 | 0 | 7 |
2019 | 3 | 1 | 4 |
2020 | 7 | 1 | 8 |
2021 | 4 | 0 | 4 |
2022 | 4 | 1 | 5 |
2023 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Neoplasms" by people in Profiles.
-
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System. JCO Oncol Pract. 2024 Jan; 20(1):59-68.
-
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors. Lung Cancer. 2023 12; 186:107417.
-
Clear cell chondrosarcoma: a review of clinicopathologic characteristics, differential diagnoses, and patient management. Hum Pathol. 2023 09; 139:126-134.
-
Breaking Up Isn't Hard to Do: Isolating Cell-free DNA Fragments in Osteosarcoma. Clin Cancer Res. 2023 06 01; 29(11):2017-2019.
-
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma. JCO Precis Oncol. 2023 03; 7:e2200334.
-
Vascularized Medial Femoral Condyle Periosteal Flaps With Allograft Bone for Distal Radius Giant Cell Tumors: A Case Report. JBJS Case Connect. 2022 07 01; 12(3).
-
Stapled peptides as scaffolds for developing radiotracers for intracellular targets: Preliminary evaluation of a radioiodinated MDM2-binding stapled peptide in the SJSA-1 osteosarcoma model. Bioorg Med Chem Lett. 2022 06 15; 66:128725.
-
LncRNA SNHG3 regulates the BMSC osteogenic differentiation in bone metastasis of breast cancer by modulating the miR-1273g-3p/BMP3 axis. Biochem Biophys Res Commun. 2022 02 26; 594:117-123.
-
SOX9 and SATB2 immunohistochemistry cannot reliably distinguish between osteosarcoma and chondrosarcoma on biopsy material. Hum Pathol. 2022 03; 121:56-64.
-
Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma. Mol Oncol. 2022 06; 16(11):2174-2194.